Anavex Encouraged by New Scientific Data Revealing Positive Role of Sigma-1 Receptors in Brain Injuries

Anavex Presents Positive Results for Both ANAVEX 2-73 and ANAVEX 3-71 in Alzheimer’s Models at 2015 AD/PD™ Conference

New Data on Two Anavex Alzheimer’s Drugs to be Unveiled at AD/PD 2015

Anavex Appoints Epilepsy and Clinical Trial Methodology Expert to Scientific Advisory Board

Anavex to Present at Sigma-1 Receptors Symposium

Anavex Appoints Scientific Advisory Board Member with Expertise in Protein Misfolding Neurodegenerative Diseases

Anavex to Present at 27th Annual ROTH Conference on March 11th

ANAVEX 2-73 Could Prevent Alzheimer’s Disease in Addition to Modifying and Treating Symptoms